HK1017622A1 - Type-2 chemokine binding proteins and methods of use therefor - Google Patents

Type-2 chemokine binding proteins and methods of use therefor

Info

Publication number
HK1017622A1
HK1017622A1 HK99102891A HK99102891A HK1017622A1 HK 1017622 A1 HK1017622 A1 HK 1017622A1 HK 99102891 A HK99102891 A HK 99102891A HK 99102891 A HK99102891 A HK 99102891A HK 1017622 A1 HK1017622 A1 HK 1017622A1
Authority
HK
Hong Kong
Prior art keywords
type
chemokine binding
methods
binding proteins
use therefor
Prior art date
Application number
HK99102891A
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of HK1017622A1 publication Critical patent/HK1017622A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Catalysts (AREA)
HK99102891A 1996-05-22 1999-07-07 Type-2 chemokine binding proteins and methods of use therefor HK1017622A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1813796P 1996-05-22 1996-05-22
PCT/US1997/008590 WO1997044054A2 (en) 1996-05-22 1997-05-21 Type-2 chemokine binding proteins and methods of use therefor

Publications (1)

Publication Number Publication Date
HK1017622A1 true HK1017622A1 (en) 1999-11-26

Family

ID=21786445

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102891A HK1017622A1 (en) 1996-05-22 1999-07-07 Type-2 chemokine binding proteins and methods of use therefor

Country Status (21)

Country Link
EP (1) EP0901379B1 (xx)
JP (1) JP2000511535A (xx)
KR (1) KR20000015895A (xx)
CN (1) CN1226171A (xx)
AT (1) ATE196091T1 (xx)
AU (1) AU3136197A (xx)
BR (1) BR9710028A (xx)
CA (1) CA2256568A1 (xx)
CZ (1) CZ378998A3 (xx)
DE (1) DE69703040T2 (xx)
DK (1) DK0901379T3 (xx)
ES (1) ES2152095T3 (xx)
GR (1) GR3034805T3 (xx)
HK (1) HK1017622A1 (xx)
IL (1) IL127166A0 (xx)
NO (1) NO985412L (xx)
NZ (1) NZ333456A (xx)
PL (1) PL330149A1 (xx)
PT (1) PT901379E (xx)
TR (1) TR199802392T2 (xx)
WO (1) WO1997044054A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
GB9916703D0 (en) 1999-07-16 1999-09-15 Alcami Antonio Viral protein binding compositions and methods
AU2001261738A1 (en) * 2000-05-17 2001-11-26 London Health Sciences Centre Compositions and methods for promoting immunosuppression
HUP0303854A2 (hu) 2000-09-08 2004-03-01 Gryhon Therapeutics, Inc. Szintetikus erythropoiesis-stimuláló proteinek
WO2002031115A2 (en) 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ES2287192T3 (es) * 2000-12-04 2007-12-16 Viron Therapeutics, Inc. Proteina inmunomoduladora derivada del virus de tumor del mono de yaba.
DE10162869A1 (de) * 2001-12-20 2003-07-31 Alexander Cherkasky Invasive lineare halb-zyklische und zyklische Systeme zur Herauslockung der Krankheitserreger
GB0304531D0 (en) * 2003-02-27 2003-04-02 Isis Innovation Treatment
ES2387275T3 (es) * 2003-05-15 2012-09-19 Genentech, Inc. Métodos y composiciones para la prevención y el tratamiento de la sepsis
BRPI0410805A (pt) 2003-09-09 2006-06-27 Fumapharm Ag uso de derivados do ácido fumárico para tratamento da insuficiência cardìaca e asma
HRP20220902T3 (hr) 2007-02-08 2022-10-14 Biogen Ma Inc. Pripravci i njihova upotreba u liječenju multiple skleroze
CN113234137B (zh) * 2021-06-21 2022-02-25 华中农业大学 分离自草鱼的CXCL20a蛋白在作为抗菌肽中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0604418B1 (en) * 1991-03-29 1998-09-23 Immunex Corporation Isolated viral protein cytokine antagonists
DK0840615T3 (da) * 1995-04-19 2003-08-18 Robarts John P Res Inst Kemokin-bindende protein og fremgangsmåder til anvendelse deraf
KR19990063653A (ko) * 1995-09-29 1999-07-26 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 케모킨 억제제

Also Published As

Publication number Publication date
AU3136197A (en) 1997-12-09
CA2256568A1 (en) 1997-11-27
JP2000511535A (ja) 2000-09-05
NO985412L (no) 1999-01-20
NZ333456A (en) 2000-08-25
DE69703040D1 (de) 2000-10-12
DE69703040T2 (de) 2001-05-03
EP0901379A2 (en) 1999-03-17
CN1226171A (zh) 1999-08-18
CZ378998A3 (cs) 1999-07-14
ES2152095T3 (es) 2001-01-16
PL330149A1 (en) 1999-04-26
KR20000015895A (ko) 2000-03-15
EP0901379B1 (en) 2000-09-06
GR3034805T3 (en) 2001-02-28
WO1997044054A2 (en) 1997-11-27
ATE196091T1 (de) 2000-09-15
WO1997044054A3 (en) 1998-05-14
DK0901379T3 (da) 2000-12-27
IL127166A0 (en) 1999-09-22
TR199802392T2 (xx) 1999-02-22
PT901379E (pt) 2001-02-28
BR9710028A (pt) 1999-08-10
NO985412D0 (no) 1998-11-20

Similar Documents

Publication Publication Date Title
WO1996033730A3 (en) Chemokine binding protein and methods of use therefor
IL127166A0 (en) Type-2 chemokine binding proteins and methods of use therefor
EP1674477A3 (en) Binding polypeptides for B lymphocyte stimulator protein (BLYS)
IL161016A (en) Polypeptides capable of ang-2 binding
WO2002032925A3 (en) Protein scaffolds for antibody mimics and other binding proteins
DE69833014D1 (de) Menschliche toll homologen
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
AU4367196A (en) Novel protein domain which binds tyrosine phosphorylated proteins
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
WO1999000407A3 (en) Improved bacillus thuringiensis toxin
WO1997044451A3 (en) Vasoactive amine binding molecules
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
ATE301194T1 (de) Beta-defensine
AU6017996A (en) P-53 binding protein called mdmx and encoding sequences for said protein
WO1991013984A3 (en) Interleukin-4 binding proteins
WO2001090183A3 (en) Human secreted protein, zsig47
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040521